If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Neuronetics"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 10: | Line 10: | ||
[[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent | [[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent | ||
| + | |||
| + | [[:Category:Neurostimulation_Techniques|Neurostimulation Technique(s)]]: TMS | ||
==Links== | ==Links== | ||
[https://neurostar.com/neuronetics/ Website] | [https://neurostar.com/neuronetics/ Website] | ||
Revision as of 19:31, 7 March 2022
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. Neuronetics became "the first company to get FDA authorization for a transcranial magnetic stimulation (TMS) device to treat major depressive disorder in 2008." They manufacture a transcranial magnetic stimulation device.
Founded in The United States around 2003, Neuronetics produces noninvasive hardware and end-user software.
Neuronetics makes tools for medical diagnosis and treatment through body/mind state interpretation and neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): TMS